{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:13:00Z","timestamp":1791493980544,"version":"4.3.4"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) is a new category of otitis media in which cases of otitis media due to ANCA-associated vasculitis (AAV) are classified, regardless of ANCA variant or ANCA serotype. We aimed to describe the clinical features and course of patients with OMAAV and identify factors associated with hearing outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analysed 30 patients with OMAAV, classified based on the criteria proposed by the Japan Otological Society in 2016.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Single-positive myeloperoxidase-ANCA, single-positive proteinase 3-ANCA, double-positive ANCA, and double-negative ANCA were identified in 47%, 33%, 7%, and 13% of the patients, respectively. All patients subjected to audiometry showed hearing impairments, and 85% were affected bilaterally. Mixed- and sensorineural-type hearing impairments were identified in 80% and 20% of impaired ears, respectively. Hypertrophic pachymeningitis (HPM) was identified in 37% of the patients. Immunosuppressive therapy was administered to 93% of patients, and the median air conduction hearing levels at pre- and post-treatment were 66.1\u2009dB and 43.4\u2009dB, respectively, indicating significant hearing improvements. HPM and a long interval between disease onset and treatment initiation were significantly correlated with poor hearing prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>OMAAV develops under any type of ANCA-serology and typically causes mixed or sensorineural bilateral hearing loss. The early initiation of immunosuppressive therapy and the absence of HPM were associated with good hearing outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roab078","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:37:26Z","timestamp":1634773046000},"page":"923-929","source":"Crossref","is-referenced-by-count":7,"title":["Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients"],"prefix":"10.1093","volume":"32","author":[{"given":"Akifumi","family":"Tabei","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-485X","authenticated-orcid":false,"given":"Toru","family":"Sakairi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Nakasatomi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hamatani","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriaki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiju","family":"Hiromura","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine , Maebashi, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"2022082013383187400_R1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21053\/ceo.2016.9.1.8","article-title":"Granulomatosis with polyangiitis in otolaryngologist practice: a review of current knowledge","volume":"9","author":"Wojciechowska","year":"2016","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"2022082013383187400_R2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00016480500437435","article-title":"Ear, nose and throat manifestations of Churg-Strauss syndrome","volume":"126","author":"Bacciu","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"2022082013383187400_R3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10067-018-4019-0","article-title":"Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes","volume":"37","author":"Felicetti","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2022082013383187400_R4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14397595.2016.1177926","article-title":"Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan","volume":"27","author":"Harabuchi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2022082013383187400_R5","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1097\/MAO.0000000000001563","article-title":"Comparison of localized and systemic otitis media with ANCA-associated vasculitis","volume":"38","author":"Okada","year":"2017","journal-title":"Otol Neurotol"},{"key":"2022082013383187400_R6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MAO.0000000000001223","article-title":"Vestibular involvement in patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"38","author":"Morita","year":"2017","journal-title":"Otol Neurotol"},{"key":"2022082013383187400_R7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.anl.2020.02.017","article-title":"Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV)","volume":"47","author":"Morita","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"2022082013383187400_R8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.anl.2020.09.004","article-title":"The hearing prognosis of otitis media with ANCA-associated vasculitis","volume":"48","author":"Iwata","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"2022082013383187400_R9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anl.2020.07.004","article-title":"Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society","volume":"48","author":"Harabuchi","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"2022082013383187400_R10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022082013383187400_R11","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022082013383187400_R12","doi-asserted-by":"crossref","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022082013383187400_R13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/03009742.2018.1498916","article-title":"Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients","volume":"48","author":"Sakairi","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2022082013383187400_R14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roab078\/41928214\/roab078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/5\/923\/45487171\/roab078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/5\/923\/45487171\/roab078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T13:38:48Z","timestamp":1661002728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/32\/5\/923\/6374722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,24]]},"published-print":{"date-parts":[[2022,8,20]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roab078","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2021,9,24]]}}}